‘It’s clearly a home run for Amgen.’--Denise...

‘It’s clearly a home run for Amgen.’

--Denise Gilbert, a biotechnology analyst, on federal approval of the sale of Amgen’s genetically engineered anti-anemia drug, erythropoietin, which is expected to help thousands of people with kidney disease